FINNENCE ▪ THE WIRE FILE
THE WIRE · № 89049
News■ Mixed
EYPT SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving EyePoint Pharmaceuticals
KINDNews
DIRECTION■ Mixed
SOURCES1
ENTITIES2
STORY SIZESTANDALONE
FIRST SEEN
LAST UPDATE
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
THE MACHINE IS STILL READING THIS ITEM — ANALYSIS LANDS WITHIN MINUTES OF INGESTION.
FULL DISPATCH
EyePoint described its Phase 3 wet AMD trials as designed in close alignment with the FDA. LUCIA then missed its primary endpoint, and LUGANO's favorable result depended on excluding nine DURAVYU patients. NEW YORK, Oct. 20, 2026 /PRNewswire/ -- Shares of EyePoint Pharmaceuticals (NASDAQ:...
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
SUBJECTNasdaq Composite · ^IXIC
SUBJECTAdvanced Micro Devices · AMD
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares ^IXIC
Dogness Receives NASDAQ Notification Regarding Minimum Bid Price Requirement2026-10-20 20:15 UTC
Dogness Receives NASDAQ Notification Regarding Minimum Bid Price Requirement2026-10-20 20:15 UTC
→CORRELATIONshares ^IXIC
FF EAI Robotics Ecosystem Inc. Announces Details for Its Listing Ceremony and Nasdaq Investor Day, Taking Place on Monday, Oct. 26, at Nasdaq's MarketSite in NYC2026-10-21 02:28 UTC
FF EAI Robotics Ecosystem Inc. Announces Details for Its Listing Ceremony and Nasdaq Investor Day, Taking Place on Monday, Oct. 26, at Nasdaq's MarketSite in NYC2026-10-21 02:28 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.